| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Cbo &COO | Chief Business Officer
3 companies
Klein Lawrence Otto is a Cbo &COO at CRISPR Therapeutics AG with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 27 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2021 | CRSP Crispr Therapeutics AG | Cbo &COO | Sale+OE | 100,000 | $128.05 | $12,805,240.00 | -87.6% | +2.5% | -49.7% | |
| Jan 15, 2021 | CRSP Crispr Therapeutics AG | Cbo &COO | Sale+OE | 25,000 | $215.20 | $5,379,939.60 | -7.2% | - | - | |
| Jun 25, 2020 | CRSP Crispr Therapeutics AG | Cbo &COO | Sale+OE | 70,000 | $75.88 | $5,311,564.12 | -22.8% | - | - | |
| May 11, 2020 | CRSP Crispr Therapeutics AG | Cbo &COO | Sale+OE | 25,000 | $60.40 | $1,509,970.58 | -38.1% | - | - | |
| Jul 11, 2019 | CRSP Crispr Therapeutics AG | Chief Business Officer | Sale+OE | 20,000 | $50.02 | $1,000,352.84 | -33.3% | - | - |